CORD-19:3f9572ae671d876279b4d2cd6b6544b24fb3e52d / 481-829 JSONTXT

Annnotations TAB JSON ListView MergeView

    CORD-19-Sentences

    {"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T5","span":{"begin":0,"end":348},"obj":"Sentence"},{"id":"TextSentencer_T5","span":{"begin":0,"end":348},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"8 So far, cathepsin D, an aspartic protease, and cysteine cathespins B, H, L, S and few others were associated with cancer progression. [9] [10] [11] [12] Cysteine cathepsins are single-gene products, but the protein products may be polymorphic, due to allelic variants of the gene, alternative RNA splicing and/or post-translational modifications."}

    CORD-19-PD-HP

    {"project":"CORD-19-PD-HP","denotations":[{"id":"T3","span":{"begin":116,"end":122},"obj":"Phenotype"}],"attributes":[{"id":"A3","pred":"hp_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/HP_0002664"}],"text":"8 So far, cathepsin D, an aspartic protease, and cysteine cathespins B, H, L, S and few others were associated with cancer progression. [9] [10] [11] [12] Cysteine cathepsins are single-gene products, but the protein products may be polymorphic, due to allelic variants of the gene, alternative RNA splicing and/or post-translational modifications."}

    CORD-19-PD-MONDO

    {"project":"CORD-19-PD-MONDO","denotations":[{"id":"T3","span":{"begin":116,"end":122},"obj":"Disease"},{"id":"T11527","span":{"begin":116,"end":122},"obj":"Disease"}],"attributes":[{"id":"A3","pred":"mondo_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/MONDO_0004992"},{"id":"A54354","pred":"mondo_id","subj":"T11527","obj":"http://purl.obolibrary.org/obo/MONDO_0004992"}],"text":"8 So far, cathepsin D, an aspartic protease, and cysteine cathespins B, H, L, S and few others were associated with cancer progression. [9] [10] [11] [12] Cysteine cathepsins are single-gene products, but the protein products may be polymorphic, due to allelic variants of the gene, alternative RNA splicing and/or post-translational modifications."}